Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Thomas Kenneth JR — CardioVascular BioTherapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Thomas Kenneth JR

Thomas Kenneth JR

V.P. of Research & Development at CardioVascular BioTherapeutics, Inc. · on record since Apr 13, 2006

Insider trading activity of Thomas Kenneth JR

Transactions on record: 1; since May 24, 2006

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 24, 2006

Figures computed from official regulatory filings — methodology.

Companies where Thomas Kenneth JR has traded

CardioVascular BioTherapeutics, Inc.1 tx · May 24, 2006

Track record of Thomas Kenneth JR

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Thomas Kenneth JR

Co-insiders of Thomas Kenneth JR

ABROMOVITZ GARY BCardioVascular BioTherapeutics, Inc.
Baik Joong-KiCardioVascular BioTherapeutics, Inc.
CardioVascular BioTherapeutics, Inc.CardioVascular BioTherapeutics, Inc.
Chanson FredericCardioVascular BioTherapeutics, Inc.
Flaa MickaelCardioVascular BioTherapeutics, Inc.
Gordon ElizabethCardioVascular BioTherapeutics, Inc.
Gordon GrantCardioVascular BioTherapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

HORN SETH ACardioVascular BioTherapeutics, Inc.

Ingram ThomasCardioVascular BioTherapeutics, Inc.

Jacobs John WCardioVascular BioTherapeutics, Inc.

Levin Robert SCardioVascular BioTherapeutics, Inc.

Montano Alexander GeneCardioVascular BioTherapeutics, Inc.

MONTANO DANIEL CCardioVascular BioTherapeutics, Inc.

Paladin Capital ManagementCardioVascular BioTherapeutics, Inc.

Pelton Judith SCardioVascular BioTherapeutics, Inc.

Priemer WolfgangCardioVascular BioTherapeutics, Inc.

ROTH VINCENT JCardioVascular BioTherapeutics, Inc.

Stegmann ThomasCardioVascular BioTherapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
CardioVascular BioTherapeutics, Inc.	May 24, 2006	Award	1	0.00	$0	SEC